Full Text Journal Articles by
Author Andrea Gallina

Advertisement

Find full text journal articles






Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab?

Filippo Pederzoli, Marco Bandini, Daniele Raggi, Laura Marandino, Giuseppe Basile, Massimo Alfano, Renzo Colombo, Andrea Salonia, Alberto Briganti, Andrea Gallina, Francesco Montorsi, Andrea Necchi,

In locally advanced and metastatic malignancies, antibiotic (ATB) therapy has a negative effect on immunotherapy efficacy. Therefore, we aimed to evaluate whether ATB therapy and use of specific ATB classes with concomitant neoadjuvant pembrolizumab affected pathologic complete response (ypT0N0) and relapse-free survival (RFS) for patients with clinical T2-4N0M0 bladder cancer ... Read more >>

Eur Urol (European urology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press: Incidental Prostate Cancer: An Example of How Important Guidelines Are, Especially When Evidence Is Limited.

Umberto Capitanio, Riccardo Autorino, Marco Bandini, Alberto Briganti, Liang Cheng, Matthew R Cooperberg, Federico Dehò, Andrea Gallina, Laurence Klotz, Brian R Lane, Rodolfo Montironi, Andrea Salonia, Christian Stief, Bertrand Tombal, Francesco Montorsi,

Eur Urol Oncol (European urology oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

Re: Paolo Dell'Oglio, Elio Mazzone, Edward Lambert, et al. The Effect of Surgical Experience on Perioperative and Oncological Outcomes After Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Evidence from a Referral Centre with Extensive Experience in Robotic Surgery. Eur Urol Focus 2021;7:352-8.

Francesco Montorsi, Giorgio Gandaglia, Federico Dehò, Andrea Gallina, Marco Moschini, Andrea Salonia, Alberto Briganti,

Eur Urol Focus (European urology focus)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy.

Alberto Martini, Luca Afferi, Stefania Zamboni, Julianne G Schultz, Chiara Lonati, Agostino Mattei, R Jeffrey Karnes, Matteo Soligo, Armando Stabile, Ettore Di Trapani, Ottavio De Cobelli, Giuseppe Simone, Claudio Simeone, Mario Alvarez-Maestro, Giorgio Gandaglia, Andrea Gallina, Renzo Colombo, Alberto Briganti, Francesco Montorsi, Evanguelos Xylinas, Shahrokh F Shariat, Marco Moschini,

<h4>Purpose</h4>Presently, major guidelines do not provide specific recommendations on oncologic surveillance for patients who harbor VH BCa at radical cystectomy. We aimed to create a personalized follow-up scheme that dynamically weighs OCM versus the risk of recurrence for VH BCa, and to compare it with a similar one for pUC.<h4>Methods</h4>Within ... Read more >>

J Urol (The Journal of urology)
[2021, :101097JU0000000000001886]

Cited: 0 times

View full text PDF listing >>



Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.

Praful Ravi, Gregory R Pond, Leonidas N Diamantopoulos, Christopher Su, Ajjai Alva, Rohit K Jain, William P Skelton, Sumati Gupta, Jonathan D Tward, Kathleen M Olson, Parminder Singh, Camilla M Grunewald, Guenter Niegisch, Jae-Lyun Lee, Andrea Gallina, Marco Bandini, Andrea Necchi, Matthew Mossanen, Bradley A McGregor, Catherine Curran, Petros Grivas, Guru P Sonpavde,

<h4>Objectives</h4>To evaluate outcomes of patients achieving a post-treatment pathological stage of <ypT2N0 at radical cystectomy (RC) following neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) to identify an optimal definition of pathological response.<h4>Patients and methods</h4>Patients from 10 international centres who underwent NAC for cT2-4aN0-1 MIBC and achieved <ypT2N0 disease at ... Read more >>

BJU Int (BJU international)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Robot-Assisted, Laparoscopic, and Open Radical Cystectomy (RC): Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy Registry (RIC)

Angelo Porreca, Gian Maria Busetto, Michele Colicchia, Katie Palmer, Walter Artibani, Alessandro Antonelli, Lorenzo Bianchi, Aldo Bocciardi, Eugenio Brunocilla, Marco Carini, Giuseppe Carrieri, Luigi Cormio, Ugo Giovanni Falagario, Ettore De Berardinis, Alessandro Sciarra, Costantino Leonardo, Francesco Del Giudice, Martina Maggi, Ottavio de Cobelli, Matteo Ferro, Gennaro Musi, Amelio Ercolino, Fabrizio Di Maida, Andrea Gallina, Carlo Introini, Ettore Mearini, Giovanni Cochetti, Andrea Minervini, Francesco Montorsi, Riccardo Schiavina, Sergio Serni, Claudio Simeone, Paolo Parma, Armando Serao, Mario Salvatore Mangano, Giorgio Pomara, Pasquale Ditonno, Alchiede Simonato, Daniele Romagnoli, Alessandro Crestani, Daniele D'Agostino,

<h4>Introduction: </h4> the Italian Radical Cystectomy Registry (RIC) is an observational prospective study aiming to understand clinical variables and patient characteristics associated with short- and long-term outcomes among bladder cancer (BC) patients undergoing radical cystectomy (RC). Moreover, it compares the effectiveness of three RC techniques - open, robotic, and laparoscopic. ... Read more >>

()
[, :]

Cited: 0 times

View full text PDF listing >>



Sex- and age-related differences in the distribution of bladder cancer metastases.

Giuseppe Rosiello, Carlotta Palumbo, Marina Deuker, Lara Franziska Stolzenbach, Thomas Martin, Zhe Tian, Andrea Gallina, Francesco Montorsi, Peter Black, Wassim Kassouf, Shahrokh F Shariat, Fred Saad, Alberto Briganti, Pierre I Karakiewicz,

<h4>Objective</h4>Our objective was to investigate age- and sex-related differences in the distribution of metastases in patients with metastatic bladder cancer.<h4>Methods</h4>Within the National Inpatient Sample database (2008-2015), we identified 7040 patients with metastatic bladder cancer. Trend test and Chi-square test analyses were used to evaluate the relationship between age and site ... Read more >>

Jpn J Clin Oncol (Japanese journal of clinical oncology)
[2021, 51(6):976-983]

Cited: 0 times

View full text PDF listing >>



Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection.

Giuseppe Rosiello, Giorgio Gandaglia, Simone Scuderi, Francesco Barletta, Nicola Fossati, Armando Stabile, Andrea Gallina, Elio Mazzone, Luca Maria Vitale, Antony Pellegrino, Carlo Bravi, Alberto Martini, Vito Cucchiara, Pierre I Karakiewicz, Alexandre Mottrie, Alberto Briganti, Francesco Montorsi,

<h4>Background</h4>Prospective data collection for perioperative outcomes might increase awareness of surgical results obtained for patients with prostate cancer (PCa) undergoing robot-assisted radical prostatectomy (RARP). This would prompt the implementation of measures aimed at reducing the risk of adverse outcomes.<h4>Objective</h4>To assess the efficacy of an audit and feedback process aimed at ... Read more >>

Eur Urol Focus (European urology focus)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Incidental Prostate Cancer (cT1a-cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer Guidelines.

Umberto Capitanio, Riccardo Autorino, Marco Bandini, Alberto Briganti, Liang Cheng, Matthew R Cooperberg, Federico Dehò, Andrea Gallina, Laurence Klotz, Brian Lane, Rodolfo Montironi, Andrea Salonia, Christian Stief, Bertrand Tombal, Francesco Montorsi,

Eur Urol Oncol (European urology oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand?

Giuseppe Basile, Filippo Pederzoli, Marco Bandini, Daniele Raggi, Andrea Gallina, Andrea Salonia, Alberto Briganti, Francesco Montorsi, Philippe E Spiess, Andrea Necchi,

<h4>Introduction</h4>The standard of care for intermediate- and high-risk non-muscle invasive bladder cancer (NMIBC) patients is transurethral resection of bladder tumor followed by intravesical adjuvant immunotherapy with Bacillus Calmette-Guerin (BCG). However, a non-negligible portion of patients is doomed to fail BCG-therapy and, consequently, undergo radical cystectomy as only treatment option available. ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab.

Andrea Necchi, Joep J de Jong, Daniele Raggi, Alberto Briganti, Laura Marandino, Andrea Gallina, Marco Bandini, Bashar Dabbas, Elai Davicioni, Umberto Capitanio, Francesco Montorsi, Roland Seiler, Jonathan L Wright, Yair Lotan, Peter C Black, Ewan A Gibb,

<h4>Background</h4>In patients with muscle-invasive urothelial bladder cancer (MIBC), molecular alterations in immunotherapy-resistant tumors found at radical cystectomy (RC) remain largely unstudied.<h4>Objective</h4>To investigate the biology of pembrolizumab-resistant tumors in comparison to an RC cohort treated without any systemic therapy and a cohort of neoadjuvant chemotherapy (NAC)-treated tumors.<h4>Design, setting, and participants</h4>Transcriptome-wide expression ... Read more >>

Eur Urol (European urology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Development and validation of a nomogram for predicting early stress urinary incontinence following endoscopic enucleation of the prostate.

Eugenio Ventimiglia, Federico Dehò, Andrea Gallina, Paolo Capogrosso, Francesco Montorsi,

World J Urol (World journal of urology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Letter - Can micro-ultrasound be the new first-choice test for patients with a suspicion of prostate cancer? RE: Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer, CUAJ, Jan 2021 (with author reply).

Francesco Montorsi, Armando Stabile, Giorgio Gandaglia, Federico Deho, Andrea Gallina, Alberto Briganti,

Can Urol Assoc J (Canadian Urological Association journal = Journal de l'Association des urologues du Canada)
[2021, 15(2):E127-E128]

Cited: 0 times

View full text PDF listing >>



Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancer.

Angelo Porreca, Katie Palmer, Walter Artibani, Alessandro Antonelli, Lorenzo Bianchi, Eugenio Brunocilla, Aldo Massimo Bocciardi, Maurizio Brausi, Gian Maria Busetto, Marco Carini, Giuseppe Carrieri, Antonio Celia, Luca Cindolo, Giovanni Cochetti, Renzo Colombo, Ettore De Berardinis, Ottavio De Cobelli, Fabrizio Di Maida, Amelio Ercolino, Franco Gaboardi, Antonio Galfano, Andrea Gallina, Michele Gallucci, Carlo Introini, Ettore Mearini, Andrea Minervini, Francesco Montorsi, Gennaro Musi, Giovannalberto Pini, Riccardo Schiavina, Silvia Secco, Sergio Serni, Claudio Simeone, Giovanni Tasso, Daniele D'Agostino,

<h4>Background</h4>Bladder cancer is the ninth most common type of cancer worldwide. In the past, radical cystectomy via open surgery has been considered the gold-standard treatment for muscle invasive bladder cancer. However, in recent years there has been a progressive increase in the use of robot-assisted laparoscopic radical cystectomy. The aim ... Read more >>

BMC Cancer (BMC cancer)
[2021, 21(1):51]

Cited: 0 times

View full text PDF listing >>



Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer.

Marco Bandini, Jeffrey S Ross, Daniele Raggi, Andrea Gallina, Maurizio Colecchia, Roberta Lucianò, Patrizia Giannatempo, Elena Farè, Filippo Pederzoli, Marco Bianchi, Renzo Colombo, Giorgio Gandaglia, Nicola Fossati, Laura Marandino, Umberto Capitanio, Federico Deho', Siraj M Ali, Russell Madison, Jon H Chung, Andrea Salonia, Alberto Briganti, Francesco Montorsi, Andrea Necchi,

<h4>Background</h4>In the PURE-01 study (NCT02736266), we aimed to evaluate the ability to predict the pathologic complete response (pT0N0) after pembrolizumab by using clinical and tumor biomarkers.<h4>Methods</h4>In an open-label, single-arm, phase 2 study, 3 courses of 200 mg pembrolizumab preceding radical cystectomy were administered in patients with T2-4aN0M0 muscle-invasive bladder cancer. The ... Read more >>

J Natl Cancer Inst (Journal of the National Cancer Institute)
[2021, 113(1):48-53]

Cited: 2 times

View full text PDF listing >>



Re: Hugh Mostafid, Ashish M. Kamat, Siamak Daneshmand, et al. Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours. Eur Urol Oncol 2021;4:12-9.

Francesco Montorsi, Marco Bandini, Marco Moschini, Federico Dehò, Andrea Gallina,

Eur Urol Oncol (European urology oncology)
[2021, 4(1):126]

Cited: 1 time

View full text PDF listing >>



Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy.

Laura Marandino, Antonella Capozza, Marco Bandini, Daniele Raggi, Elena Farè, Filippo Pederzoli, Andrea Gallina, Umberto Capitanio, Marco Bianchi, Giorgio Gandaglia, Nicola Fossati, Maurizio Colecchia, Patrizia Giannatempo, Gianluca Serafini, Barbara Padovano, Andrea Salonia, Alberto Briganti, Francesco Montorsi, Alessandra Alessi, Andrea Necchi,

<h4>Background</h4>Data regarding the incidence and prognostic impact of immune-related imaging changes, assessed by <sup>18</sup>[F] fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scan, in patients receiving immune-checkpoint inhibitors (ICIs) are lacking. We relied on the population of patients enrolled in the PURE-01 study to evaluate such changes.<h4>Objective</h4>To evaluate the role of ... Read more >>

Eur Urol Focus (European urology focus)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Racial differences in the distribution of bladder cancer metastases: a population-based analysis.

Giuseppe Rosiello, Carlotta Palumbo, Marina Deuker, Lara Franziska Stolzenbach, Thomas Martin, Zhe Tian, Andrea Gallina, Francesco Montorsi, Peter Black, Wassim Kassouf, Shahrokh F Shariat, Fred Saad, Alberto Briganti, Pierre I Karakiewicz,

<h4>Introduction</h4>Bladder cancer is the second most common genitourinary malignancy in the United States. The incidence of bladder cancer rises with age, and it is two times more common in Caucasians than in African-Americans (23.1 vs. 12.6 cases/100,000 persons). We aimed to investigate the racial and age-related differences in the distribution ... Read more >>

Cent European J Urol (Central European journal of urology)
[2020, 73(4):407-415]

Cited: 0 times

View full text PDF listing >>



[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab.

Laura Marandino, Antonella Capozza, Marco Bandini, Daniele Raggi, Elena Farè, Filippo Pederzoli, Andrea Gallina, Umberto Capitanio, Marco Bianchi, Giorgio Gandaglia, Nicola Fossati, Maurizio Colecchia, Patrizia Giannatempo, Gianluca Serafini, Barbara Padovano, Andrea Salonia, Alberto Briganti, Francesco Montorsi, Alessandra Alessi, Andrea Necchi,

<h4>Background</h4>Data regarding the role of positron emission tomography/computed tomography (PET/CT) to stage lymph nodes in patients receiving neoadjuvant immunotherapy before radical cystectomy are lacking. The aim of this study is to evaluate the role of PET/CT to predict the pathologic lymph node involvement (LNI) in patients with MIBC receiving neoadjuvant ... Read more >>

Urol Oncol (Urologic oncology)
[2021, 39(4):235.e15-235.e21]

Cited: 0 times

View full text PDF listing >>



The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis.

Giuseppe Rosiello, Carlotta Palumbo, Angela Pecoraro, Stefano Luzzago, Marina Deuker, Lara Franziska Stolzenbach, Zhe Tian, Andrea Gallina, Giorgio Gandaglia, Francesco Montorsi, Shahrokh F Shariat, Fred Saad, Alberto Briganti, Pierre I Karakiewicz,

<h4>Background</h4>The increased awareness regarding the sex gap in bladder cancer (BCa) care over the last decade may have resulted in more timely-wise referral patterns and treatment of female patients with BCa. Thus, we tested the association of sex with disease stage at presentation, as well as with cancer-specific mortality (CSM) ... Read more >>

Urol Oncol (Urologic oncology)
[2021, 39(4):236.e1-236.e7]

Cited: 1 time

View full text PDF listing >>



Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer.

Marco Moschini, Luca Afferi, Giorgio Gandaglia, David D'Andrea, Stefania Zamboni, Carlo Di Bona, Livio Mordasini, Agostino Mattei, Philipp Baumeister, Alberto Martini, Giusy Burgio, Shahrokh F Shariat, Rafael Sanchez-Salas, Xavier Cathelineau, Armando Stabile, Emanuele Zaffuto, Andrea Salonia, Renzo Colombo, Andrea Necchi, Francesco Montorsi, Alberto Briganti, Andrea Gallina,

<h4>Background</h4>A prospective randomized trial (LEA AUO AB 25/02) found no survival benefit in extended compared with limited pelvic lymph node dissection (PLND) templates in bladder cancer (BCa) patients treated with radical cystectomy (RC). However, the rate of lymph node invasion (LNI) in the standard and extended templates was lower than ... Read more >>

Eur Urol Focus (European urology focus)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Neoadjuvant Chemotherapy or Immunotherapy for Clinical T2N0 Muscle-invasive Bladder Cancer: Time to Change the Paradigm?

Filippo Pederzoli, Marco Bandini, Laura Marandino, Daniele Raggi, Patrizia Giannatempo, Andrea Salonia, Andrea Gallina, Alberto Briganti, Francesco Montorsi, Andrea Necchi,

A 41-yr-old, otherwise healthy, premenopausal woman presented at our uro-oncology clinic with a diagnosis of muscle-invasive bladder cancer following a transurethral resection of the bladder performed at another center. After a thorough discussion with the patient, she was enrolled in the phase II PURE-01 trial (NCT02736266), testing three cycles of ... Read more >>

Eur Urol Oncol (European urology oncology)
[2020, :]

Cited: 1 time

View full text PDF listing >>



Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639-41.

Giuseppe Basile, Marco Bandini, Filippo Pederzoli, Andrea Gallina, Andrea Necchi,

Eur Urol Focus (European urology focus)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Is it Time to Consider Eliminating Surgery from the Treatment of Locally Advanced Bladder Cancer?

Andrea Necchi, Laura Marandino, Daniele Raggi, Marco Bandini, Andrea Gallina, Marco Moschini, Alberto Briganti, Francesco Montorsi,

The similar clinical behavior, overlapping therapeutic patterns, and several clinical trials addressing the neoadjuvant and first-line therapy settings for bladder cancer support the call for a more uniform definition of "locally advanced" disease. We highlight the diverse therapeutic opportunities that patients with locally advanced bladder cancer may receive at present. ... Read more >>

Eur Urol (European urology)
[2021, 79(6):713-716]

Cited: 0 times

View full text PDF listing >>



Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis.

Marco Moschini, Stefania Zamboni, Luca Afferi, Benjamin Pradere, Mohammad Abufaraj, Francesco Soria, David D'Andrea, Morgan Roupret, Alexandre De la Taille, Claudio Simeone, Agostino Mattei, Romain Mathieu, Karim Bensalah, Manfred Peter Wirth, Francesco Montorsi, Alberto Briganti, Andrea Gallina, Giuseppe Simone, Michele Gallucci, Carlo Di Bona, Giancarlo Marra, Andrea Mari, Ettore Di Trapani, Mario Alvarez Maestro, Wojciech Krajewski, Shahrokh F Shariat, Evanguelos Xylinas, Philipp Baumeister,

<h4>Objectives</h4>To compare oncological outcomes of open (ORNU) and laparoscopic radical nephroureterectomy (LRNU) after controlling for preoperative patient-derived factors.<h4>Patients and methods</h4>We evaluated a multi-institutional collaborative database composed of 3984 patients diagnosed with upper tract urothelial carcinoma (UTUC) treated with RNU between 2006 and 2018. To adjust for potential selection bias, propensity ... Read more >>

Arab J Urol (Arab journal of urology)
[2020, 19(1):31-36]

Cited: 1 time

View full text PDF listing >>



Advertisement

Disclaimer
1.115 s